SCHEMBL19169809

SCHEMBL19169809

Cc1nc(-c2ccccc2)c2c(n1)oc1ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.44
▸ LMNA P02545 2/20 0.44
▸ ALDH1A1 P00352 7/20 0.42
▸ HPGD P15428 6/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ CSF1R P07333 1/20 0.41
▸ PDGFRB P09619 1/20 0.41
▸ KIT P10721 1/20 0.41
▸ FLT3 P36888 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ HSD17B10 Q99714 4/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ USP2 O75604 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ DUSP3 P51452 1/20 0.39
▸ PTPN5 P54829 1/20 0.39
▸ PTPN11 Q06124 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19170016 0.97 SMN1; SMN2 (0.42) SMN1; SMN2LMNAALDH1A1HPGDMEN1
SCHEMBL19169964 0.84 HPGD (0.40) SMN1; SMN2LMNAALDH1A1HPGDMEN1
SCHEMBL16902387 0.83 KMT2A (0.43) SMN1; SMN2LMNAALDH1A1HPGDMEN1
SCHEMBL19161626 0.82 MEN1 (0.42) SMN1; SMN2LMNAALDH1A1HPGDMEN1
SCHEMBL24961651 0.81 MEN1 (0.41) SMN1; SMN2LMNAALDH1A1HPGDMEN1
SCHEMBL18017879 0.81 MEN1 (0.45) SMN1; SMN2LMNAALDH1A1HPGDMEN1
SCHEMBL17297404 0.81 ALDH1A1 (0.47) SMN1; SMN2LMNAALDH1A1HPGDMEN1
SCHEMBL18017783 0.81 MEN1 (0.45) SMN1; SMN2LMNAALDH1A1HPGDMEN1
SCHEMBL18017923 0.81 MEN1 (0.45) SMN1; SMN2LMNAALDH1A1HPGDMEN1
SCHEMBL24474638 0.81 SMN1; SMN2 (0.43) SMN1; SMN2LMNAALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301189-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-21 — — US disclosed
US-20230301189-A1 ORGANIC ELECTROLUMINESCENT DEVICE Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-09-21 — — US disclosed
EP-3305792-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME LG Chem, Ltd. (KR) 2018-04-11 — — EP disclosed
US-20170213984-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME LG CHEM, LTD. (KR) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170213984-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, NOS1, NOLC1 SMN1; SMN2 3568/4885LMNA 3140/4885ALDH1A1 331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback